Steven Paul Cohen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Steven Paul Cohen has a total of 832 co-authors. Here are the top co-authors by number of shared publications:
- Fabíola Costa
Sword Health
29 shared publications - Fernando Dias Correia
SWORD Health, Porto, Portugal
29 shared publications - Dora Janela
Sword Health, Inc, Draper, UT, USA
28 shared publications Connie Kurihara
Department of Physical Medicine & Rehabilitation, Walter Reed National Military Medical Center, Bethesda, Maryland, USA
27 shared publications- Vijay Yanamadala
Hartford Healthcare
27 shared publications - Maria Molinos
SWORD Health, Inc., Draper, UT 84043, USA
26 shared publications
Latest Publications
- 16 October 2026
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 145 (6) , 1575-1577
Transversus Abdominis Plane Blocks in Surgery: Comment
Was not provided for this article.
- 16 October 2026
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 145 (6) , 1575-1577
Transversus Abdominis Plane Blocks in Surgery: Comment
Was not provided for this article.
- 1 October 2026
- Published by Taylor & Francis in Pain Management
- p. 1-11
Multi-center, randomized controlled efficacy and comparative-effectiveness study evaluating ketamine, stellate ganglion blocks, combination treatment, and sham treatments for posttraumatic stress disorder and traumatic brain injury-associated headache: a study protocol
1. Traumatic brain injury and PTSD are signature injuries of war, and along with chronic pain, are known as the polytrauma triad. Traumatic Brain Injury (TBI) affects approximately 50,000,000 peopl...
- 1 October 2026
- Published by Taylor & Francis in Pain Management
- p. 1-11
Multi-center, randomized controlled efficacy and comparative-effectiveness study evaluating ketamine, stellate ganglion blocks, combination treatment, and sham treatments for posttraumatic stress disorder and traumatic brain injury-associated headache: a study protocol
1. Traumatic brain injury and PTSD are signature injuries of war, and along with chronic pain, are known as the polytrauma triad. Traumatic Brain Injury (TBI) affects approximately 50,000,000 peopl...
- 2 September 2026
- Published by Oxford University Press (OUP) in Pain Medicine
Does the National Resident Matching Program rank list predict Accreditation Council for Graduate Medical Education trainee performance among multispecialty pain medicine fellows? A multicenter study
Background: Training programs seek to match fellows who will perform well during training. The National Resident Matching Program (NRMP) allows programs to choose the most capable trainees, with higher-ranked applicants expected to perform better. Pain medicine is one of the most popular non–internal medicine fellowships in the United States, and the existence of multiple specialty pathways for entry makes candidate selection challenging. Objective: The aim of this study is to correlate fellow rank order and match number with academic performance. Methods: Match information and fellow performance from 4 highly ranked multispecialty pain programs were obtained, with performance evaluated on the basis of the 6 final Accreditation Council for Graduate Medical Education (ACGME) core competencies. The primary analysis correlated each fellow’s relative rank-list position with relative subsequent ACGME performance within the same institution and fellowship cohort using cohort-relative percentile ranks, Spearman correlation, stratified permutation testing, and stratified bootstrap confidence intervals. Sensitivity and exploratory analyses used absolute/converted match-number fixed-effects regression, Kendall Tau-B, sex stratification, and domain-specific correlations with false discovery rate adjustment. Results: The primary analysis included 93 fellows across 20 institution/cohort strata. Rank-list standing was not significantly associated with ACGME performance (Spearman r = 0.06; 95% CI −0.19 to 0.32; P = .63), and sensitivity, sex-stratified, and domain-specific analyses were also nonsignificant. When stratified according to top-, middle- and bottom-ranked applicants, all domains were significant, with bottom-ranked fellows faring worse than other groups. Conclusions: Pain medicine rank lists correlate poorly with fellowship performance, though a weak association was noted wherein bottom-ranked applicants performed worse. This suggests that the metrics used to rank pain medicine applicants, those used to measure performance, or both require modification.
- 2 September 2026
- Published by Oxford University Press (OUP) in Pain Medicine
Does the National Resident Matching Program rank list predict Accreditation Council for Graduate Medical Education trainee performance among multispecialty pain medicine fellows? A multicenter study
Background: Training programs seek to match fellows who will perform well during training. The National Resident Matching Program (NRMP) allows programs to choose the most capable trainees, with higher-ranked applicants expected to perform better. Pain medicine is one of the most popular non–internal medicine fellowships in the United States, and the existence of multiple specialty pathways for entry makes candidate selection challenging. Objective: The aim of this study is to correlate fellow rank order and match number with academic performance. Methods: Match information and fellow performance from 4 highly ranked multispecialty pain programs were obtained, with performance evaluated on the basis of the 6 final Accreditation Council for Graduate Medical Education (ACGME) core competencies. The primary analysis correlated each fellow’s relative rank-list position with relative subsequent ACGME performance within the same institution and fellowship cohort using cohort-relative percentile ranks, Spearman correlation, stratified permutation testing, and stratified bootstrap confidence intervals. Sensitivity and exploratory analyses used absolute/converted match-number fixed-effects regression, Kendall Tau-B, sex stratification, and domain-specific correlations with false discovery rate adjustment. Results: The primary analysis included 93 fellows across 20 institution/cohort strata. Rank-list standing was not significantly associated with ACGME performance (Spearman r = 0.06; 95% CI −0.19 to 0.32; P = .63), and sensitivity, sex-stratified, and domain-specific analyses were also nonsignificant. When stratified according to top-, middle- and bottom-ranked applicants, all domains were significant, with bottom-ranked fellows faring worse than other groups. Conclusions: Pain medicine rank lists correlate poorly with fellowship performance, though a weak association was noted wherein bottom-ranked applicants performed worse. This suggests that the metrics used to rank pain medicine applicants, those used to measure performance, or both require modification.
- Open Access
- 27 August 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e97501
Addendum: Exploring the Importance of Race and Gender Concordance Between Patients and Physical Therapists in Digital Rehabilitation for Musculoskeletal Conditions: Observational, Longitudinal Study
- 27 August 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e97501
Open AccessAddendum: Exploring the Importance of Race and Gender Concordance Between Patients and Physical Therapists in Digital Rehabilitation for Musculoskeletal Conditions: Observational, Longitudinal Study
- Open Access
- 27 August 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e97493
Addendum: Impacts of Digital Care Programs for Musculoskeletal Conditions on Depression and Work Productivity: Longitudinal Cohort Study
- 27 August 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e97493
Open AccessAddendum: Impacts of Digital Care Programs for Musculoskeletal Conditions on Depression and Work Productivity: Longitudinal Cohort Study
- Open Access
- 27 August 2026
- Published by JMIR Publications Inc. in JMIR Rehabilitation and Assistive Technologies
- Vol. 13, e97495
Addendum: Managing Musculoskeletal Pain in Older Adults Through a Digital Care Solution: Secondary Analysis of a Prospective Clinical Study
- 27 August 2026
- Published by JMIR Publications Inc. in JMIR Rehabilitation and Assistive Technologies
- Vol. 13, e97495
Open AccessAddendum: Managing Musculoskeletal Pain in Older Adults Through a Digital Care Solution: Secondary Analysis of a Prospective Clinical Study
- 13 August 2026
- Published by Elsevier in Osteoarthritis and Cartilage
Osteoarthritis pain extends beyond the nociceptive phenotype
- 13 August 2026
- Published by Elsevier in Osteoarthritis and Cartilage
Osteoarthritis pain extends beyond the nociceptive phenotype
- 6 July 2026
- Published by Oxford University Press (OUP) in Pain Medicine
Genicular nerve radiofrequency treatment for chronic knee osteoarthritis pain:a systematic review and meta-analysis of randomized controlled trials utilizing image guidance
Objective: Genicular nerve radiofrequency (gRF) treatment is a widely used intervention for chronic pain from knee osteoarthritis (KOA). This systematic review and meta-analysis focuses on RCTs utilizing image guidance to address inconsistencies in previous reviews and provide higher-quality evidence. Design, Setting, and Methods: This study included RCTs that compared gRF techniques (conventional, cooled, pulsed, bipolar) to non-gRF treatments, including sham procedures, intra-articular injections, ozone therapy, and oral medications. Primary and secondary outcomes were changes in pain and total WOMAC scores at 3, and 6 months post-gRF treatments. Subgroup analyses explored differences by lesion size, use of prognostic blocks, industry sponsorship, and study location. Statistical heterogeneity was assessed via I2 statistics. Results: Eleven RCTs with 868 knee osteoarthritis patients (435 gRF, 433 non-gRF) were included. gRF significantly reduced pain at 3 months (SMD −1.04, 95% CI: −1.48 to −0.60, I2 = 71%, P = .001) and 6 months (SMD −1.09, 95% CI: −1.87 to −0.31, I2 = 89%, P = .020). Secondary analyses showed gRF significantly reduced total WOMAC scores at 3 months, but no significant difference in total WOMAC scores between the gRF and control groups at 6 months. Subgroup analysis showed that industry sponsoredstudies reported significant 3- month pain reduction, whereas non-sponsored studies did not. This effect was independent of lesion size. Conclusions: gRF provides short- to medium-term pain relief, extending to 6 months, and may improve functional outcomes at 3 months compared with non-gRF treatments; however, evidence for sustained functional benefit remains limited. Further well-designed, adequately powered randomized controlled trials with longer follow-up are needed to determine the durability of pain relief and functional improvement following gRF.
- 6 July 2026
- Published by Oxford University Press (OUP) in Pain Medicine
Genicular nerve radiofrequency treatment for chronic knee osteoarthritis pain:a systematic review and meta-analysis of randomized controlled trials utilizing image guidance
Objective: Genicular nerve radiofrequency (gRF) treatment is a widely used intervention for chronic pain from knee osteoarthritis (KOA). This systematic review and meta-analysis focuses on RCTs utilizing image guidance to address inconsistencies in previous reviews and provide higher-quality evidence. Design, Setting, and Methods: This study included RCTs that compared gRF techniques (conventional, cooled, pulsed, bipolar) to non-gRF treatments, including sham procedures, intra-articular injections, ozone therapy, and oral medications. Primary and secondary outcomes were changes in pain and total WOMAC scores at 3, and 6 months post-gRF treatments. Subgroup analyses explored differences by lesion size, use of prognostic blocks, industry sponsorship, and study location. Statistical heterogeneity was assessed via I2 statistics. Results: Eleven RCTs with 868 knee osteoarthritis patients (435 gRF, 433 non-gRF) were included. gRF significantly reduced pain at 3 months (SMD −1.04, 95% CI: −1.48 to −0.60, I2 = 71%, P = .001) and 6 months (SMD −1.09, 95% CI: −1.87 to −0.31, I2 = 89%, P = .020). Secondary analyses showed gRF significantly reduced total WOMAC scores at 3 months, but no significant difference in total WOMAC scores between the gRF and control groups at 6 months. Subgroup analysis showed that industry sponsoredstudies reported significant 3- month pain reduction, whereas non-sponsored studies did not. This effect was independent of lesion size. Conclusions: gRF provides short- to medium-term pain relief, extending to 6 months, and may improve functional outcomes at 3 months compared with non-gRF treatments; however, evidence for sustained functional benefit remains limited. Further well-designed, adequately powered randomized controlled trials with longer follow-up are needed to determine the durability of pain relief and functional improvement following gRF.
- Open Access
- 3 July 2026
- Published by Oxford University Press (OUP) in Pain Medicine
A Multicenter Randomized Pragmatic Trial Comparing Intra-Articular Injection, Genicular Nerve Block, and Radiofrequency Ablation for Knee Osteoarthritis Pain: SKOAP Phase 2 Protocol
Background: Knee osteoarthritis (KOA) is a leading cause of chronic pain and disability worldwide, yet clinical guidelines disagree on how to escalate care when conservative management fails. Procedural interventions, including intra-articular injections, genicular nerve blocks (GNB), and genicular nerve radiofrequency ablation (GN-RFA), are used widely, but head-to-head comparative evidence is limited and recent RFA trials have produced inconsistent results, in part because prior studies have used controls that do not adequately mimic the procedural experience of the active arm. Methods/Design: SKOAP Phase 2 is a multisite, pragmatic, randomized comparative-effectiveness trial that is expected to enroll at least 900 knees across 30 U.S. centers. Knees will be randomized 1:1:1 to one of three interventions: (1) image-guided intra-articular hyaluronic acid combined with corticosteroid and local anesthetic (IA-HA+); (2) image-guided GNB with sustained-release liposomal bupivacaine and corticosteroid, followed by a sham radiofrequency procedure; or (3) comprehensive GN-RFA with post-lesioning corticosteroid injection. Participants randomized to GNB or GN-RFA will remain blinded to allocation for 12 weeks, supported by harmonized procedural environments, identical sedation and imaging protocols, a standardized sham-RFA sequence, and restricted documentation. This blinding design is rarely implemented in prior RFA trials and is central to the study's methodological rigor. The primary outcome is change in the modified Brief Pain Inventory (mBPI) from baseline to 12 weeks; secondary outcomes included pain interference, physical function, quality of life, and global improvement. Effectiveness will be evaluated using three prespecified estimands (modified intention-to-treat, receipt of intervention, and minimum effective dose) using augmented inverse-weighting methods that account for off-schedule assessments, loss to follow-up, and when appropriate non-adherence. Discussion: By combining pragmatic design with rigorous sham-controlled blinding and prespecified estimands, SKOAP Phase 2 will generate the most methodologically robust comparative evidence to date on procedural management of KOA pain and will directly inform guidelines and clinical decision-making on non-operative interventions including when and whether to escalate from intra-articular injection to nerve block to ablation.
- 3 July 2026
- Published by Oxford University Press (OUP) in Pain Medicine
Open AccessA Multicenter Randomized Pragmatic Trial Comparing Intra-Articular Injection, Genicular Nerve Block, and Radiofrequency Ablation for Knee Osteoarthritis Pain: SKOAP Phase 2 Protocol
Background: Knee osteoarthritis (KOA) is a leading cause of chronic pain and disability worldwide, yet clinical guidelines disagree on how to escalate care when conservative management fails. Procedural interventions, including intra-articular injections, genicular nerve blocks (GNB), and genicular nerve radiofrequency ablation (GN-RFA), are used widely, but head-to-head comparative evidence is limited and recent RFA trials have produced inconsistent results, in part because prior studies have used controls that do not adequately mimic the procedural experience of the active arm. Methods/Design: SKOAP Phase 2 is a multisite, pragmatic, randomized comparative-effectiveness trial that is expected to enroll at least 900 knees across 30 U.S. centers. Knees will be randomized 1:1:1 to one of three interventions: (1) image-guided intra-articular hyaluronic acid combined with corticosteroid and local anesthetic (IA-HA+); (2) image-guided GNB with sustained-release liposomal bupivacaine and corticosteroid, followed by a sham radiofrequency procedure; or (3) comprehensive GN-RFA with post-lesioning corticosteroid injection. Participants randomized to GNB or GN-RFA will remain blinded to allocation for 12 weeks, supported by harmonized procedural environments, identical sedation and imaging protocols, a standardized sham-RFA sequence, and restricted documentation. This blinding design is rarely implemented in prior RFA trials and is central to the study's methodological rigor. The primary outcome is change in the modified Brief Pain Inventory (mBPI) from baseline to 12 weeks; secondary outcomes included pain interference, physical function, quality of life, and global improvement. Effectiveness will be evaluated using three prespecified estimands (modified intention-to-treat, receipt of intervention, and minimum effective dose) using augmented inverse-weighting methods that account for off-schedule assessments, loss to follow-up, and when appropriate non-adherence. Discussion: By combining pragmatic design with rigorous sham-controlled blinding and prespecified estimands, SKOAP Phase 2 will generate the most methodologically robust comparative evidence to date on procedural management of KOA pain and will directly inform guidelines and clinical decision-making on non-operative interventions including when and whether to escalate from intra-articular injection to nerve block to ablation.